4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-25-004192
Chief Commercial Officer sold 1,083 shares at $80.05 ($86,694)
- Chief Commercial Officer acquired 1,083 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,083 | $13.28 | $14,382 | 21,926 | D |
| 2025-01-07 | Sale : show line 2 in the form 10b5-1 | −1,083 | $80.05 | $86,694 | 20,843 | D |
| Open-market sales · 1,083 sh · avg $80.05 · $86,694 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-07 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −1,083 | 15,167 | D |
Loading xslF345X05/ownership.xml…